Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
QuintilesIMS
Queensland Health
Accenture
Johnson and Johnson
Harvard Business School
Daiichi Sankyo
Chinese Patent Office
Fuji

Generated: August 21, 2018

DrugPatentWatch Database Preview

BRETHAIRE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Brethaire patents expire, and what generic alternatives are available?

Brethaire is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in BRETHAIRE is terbutaline sulfate. There are seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.

Summary for BRETHAIRE
Drug patent expirations by year for BRETHAIRE
Medical Subject Heading (MeSH) Categories for BRETHAIRE
Synonyms for BRETHAIRE
(+-)-5-(2-((1,1-Dimethylethyl)amino)-1-hydroxyethyl)-1,3-benzenediol
(+-)-Terbutaline
031T256
031T325
1-(3',5'-dihydroxyphenyl)-2-(t-butylamino)-ethanol
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)- (9CI)
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-, (+-)-
1,3-Benzenediol, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-(9CI)
1,3-Benzenediol, 5-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-
2-t-Butylamino-1-(3,5-dihydroxyphenyl)ethanol
2-t-Butylamino-1-[3,5-dihydroxyphenyl]ethanol
23031-25-6
23031-32-5
23031-32-5 (Sulfate)
46719-29-3
5- benzene-1,3-diol
5-(2-((1,1-DIMETHYLETHYL)AMINO)-1-HYDROXYETHYL)-1,3-BENZENEDIOL
5-(2-(tert-Butylamino)-1-hydroxyethyl)benzene-1,3-diol
5-(2-(tert-butylamino)-1-hydroxyethyl)benzene-1,3-diol hemisulfate
5-[2-(tert-Butylamino)-1-hydroxyethyl]-1,3-benzenediol #
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol, 5
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol; sulfuric acid
5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol;sulfuric acid
5-[2-(tert-butylamino)-1-oxidanyl-ethyl]benzene-1,3-diol
5-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}benzene-1,3-diol
A816514
AB00053548
AB00053548_15
AC-12158
AC1L1KA2
AC1L9AZM
AC1LCWBJ
ACM23031256
AK129818
AKOS015889885
AKOS015909692
AKOS015960700
alpha-[(tert-butylamino)methyl]-3,5-dihydroxybenzenemethanol
Ambap23031-32-5
API0005421
API0005740
Asthmasian
Asthmasian (TN)
AX8152612
BDBM25770
Benzyl alcohol, .alpha.-((t-butylamino)methyl)-3,5-dihydroxy-
Benzyl alcohol, alpha-((t-butylamino)methyl)-3,5-dihydroxy-
bis(5-(2-(tert-butylamino)-1-hydroxyethyl)benzene-1,3-diol) sulfate
BPBio1_000663
BRD-A50157456-065-02-4
Brethaire (Salt/Mix)
Brethaire (TN)
Brethine
Brethine (TN)
Brican
Bricanyl
Bricanyl (Salt/Mix)
Bricanyl (TN)
Bricar
Bricaril
Bricyn
BRN 2370513
BSPBio_000601
BSPBio_002066
C07129
C24H40N2O10S
CAS-23031-32-5
CCG-205201
CCG-220391
CCG-222430
CCG-39265
CHEBI:9449
CHEBI:9450
CHEMBL1160544
CHEMBL1315867
CHEMBL1760
CPD001496939
CTK8E4128
CTK8G3346
D00688
D08570
D0M8RC
DB00871
DivK1c_000078
DSSTox_CID_25437
DSSTox_GSID_45437
DSSTox_RID_80878
DTXSID3045437
DTXSID7021310
EINECS 245-385-8
EU-0101126
F2173-0944
FT-0654976
FT-0674863
GTPL560
HMS1569O03
HMS1921C15
HMS2092K19
HMS2096O03
HMS2231H10
HMS3259J05
HMS3263B13
HMS3372I16
HMS500D20
I01-3464
I14-31834
IDI1_000078
J-014950
KB-243251
KBio1_000078
KBio2_001510
KBio2_004078
KBio2_006646
KBio3_001566
KBioGR_001539
KBioSS_001510
KS-00001F8N
KWD 2019
KWD-2019
L000594
Lopac0_001126
LP01126
LS-29961
LS-7713
MFCD00079584
MLS000069693
MLS001148384
MolPort-003-959-699
NC00619
NCGC00016010-03
NCGC00016010-04
NCGC00016010-06
NCGC00016010-09
NCGC00016772-01
NCGC00089821-02
NCGC00094394-01
NCGC00094789-01
NCGC00094789-02
NCGC00094789-03
NCGC00094789-04
NCGC00261811-01
NINDS_000078
NSC-757336
NSC757336
Opera_ID_498
Oprea1_823972
OR055036
OR076314
OR207698
OR341424
PDSP1_000158
PDSP2_000157
Pharmakon1600-01500558
Prestwick_598
Prestwick0_000391
Prestwick1_000391
Prestwick2_000391
Prestwick3_000391
REGID_for_CID_657301
SAM002589944
SBB063955
SBI-0051094.P004
SCHEMBL26462
SCHEMBL41870
SCHEMBL4391
SMR000058516
SPBio_001453
SPBio_002522
Spectrum_001030
SPECTRUM1500558
Spectrum2_001327
Spectrum3_000593
Spectrum4_000870
Spectrum5_001262
SR-01000000174
SR-01000000174-2
sulfuric acid; bis(terbutaline)
T 2528
Terbutalin
Terbutalin sulfate
Terbutalina
Terbutalina [DCIT]
terbutaline
Terbutaline (INN)
Terbutaline (sulfate de)
Terbutaline (sulfate)
Terbutaline [INN:BAN]
TERBUTALINE HEMISULFATE
Terbutaline hemisulfate salt
Terbutaline sulfate
Terbutaline sulfate (JP17/USP)
Terbutaline sulfate (Salt/Mix)
Terbutaline sulfate, British Pharmacopoeia (BP) Reference Standard
Terbutaline sulfate, European Pharmacopoeia (EP) Reference Standard
Terbutaline sulfate, United States Pharmacopeia (USP) Reference Standard
Terbutaline sulfuric acid
Terbutaline,(+/-)
Terbutaline(sulfate)
Terbutalini sulfas
Terbutalino
Terbutalino [INN-Spanish]
Terbutalinum
Terbutalinum [INN-Latin]
Tox21_110602
Tox21_110602_1
Tox21_501126
TR-036208
V0238
VA11844
VU0244552-7
XWTYSIMOBUGWOL-UHFFFAOYSA-N

US Patents and Regulatory Information for BRETHAIRE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis BRETHAIRE terbutaline sulfate AEROSOL, METERED;INHALATION 018762-001 Aug 17, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for BRETHAIRE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis BRETHAIRE terbutaline sulfate AEROSOL, METERED;INHALATION 018762-001 Aug 17, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis BRETHAIRE terbutaline sulfate AEROSOL, METERED;INHALATION 018762-001 Aug 17, 1984 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Chubb
Merck
Cantor Fitzgerald
Cerilliant
Medtronic
Express Scripts
Federal Trade Commission
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.